The sudden focus on pharmaceutical shares is due to a new executive order signed by US President Donald Trump on Monday.

US stock futures are trading marginally in the red after a strong rally on Monday, marking their best single-day gain since ...

Daniel McClory, head of equity capital markets and China at US underwriter Boustead Securities, said he had “30 IPOs in process right now and more than a third are for [companies in] south-east Asia ...